633
Views
10
CrossRef citations to date
0
Altmetric
Review Article

A bounding quantitative cancer risk assessment for occupational exposures to asphalt emissions during road paving operations

ORCID Icon, ORCID Icon, &
Pages 713-737 | Received 01 Jul 2018, Accepted 21 Sep 2018, Published online: 27 Dec 2018

References

  • [ACGIH] American Conference of Governmental Industrial Hygienists. 2001. Documentation for asphalt (bitumen) fumes. In: Documentation of the Threshold Limit Values and Biological Exposure Indices (Seventh Edition). Cincinnati (OH): ACGIH; p. 22.
  • [API] American Petroleum Institute. 2009. Asphalt category analysis and hazard characterization. Petroleum HPV testing group. Submitted to US EPA. p. 54. July 14.
  • Asphalt Institute Inc. 2015. The Bitumen Industry – A global perspective: production, chemistry, use, specification and occupational exposure (Third Edition). European Bitumen Association - Eurobitume. Information Series No. 230 (IS-230) p. 60.
  • [ARMA] Asphalt Roofing Manufacturers Association, Bitumen Waterproofing Association (BWA), National Roofing Contractors Association (NRCA), Roof Coatings Manufacturers Association (RCMA). 2011. The Bitumen Roofing Industry – A Global Perspective: Production, Use, Properties, Specifications and Occupational Exposure (Second Edition). Washington (DC): ARMA, BWA, NRCA and RCMA.
  • Behrens T, Schill W, Ahrens W. 2009. Elevated cancer mortality in a German cohort of bitumen workers: extended follow-up through 2004. J Occup Environ Hyg. 6:555–561.
  • Bender AP, Parker DL, Johnson RA, Scharber WK, Williams AN, Marbury MC, Mandel JS. 1989. Minnesota highway maintenance worker study: cancer mortality. Am J Ind Med. 15:545–556.
  • Boffetta P, Burstyn I, Partanen T, Kromhout H, Svane O, Langard S, Jarvholm B, Frentzel-Beyme R, Kauppinen T, Stucker I, et al. 2001. IARC Epidemiological Study of Cancer Mortality Among European Asphalt Workers. International Agency for Research on Cancer (IARC) IARC Internal Report No. 01/003, October.
  • Boffetta P, Burstyn I, Partanen T, Kromhout H, Svane O, Langard S, Jarvholm B, Frentzel-Beyme R, Kauppinen T, Stucker I, et al. 2003a. Cancer mortality among European asphalt workers: an international epidemiological study. I. Results of the analysis based on job titles. Am J Ind Med. 43:18–27.
  • Boffetta P, Burstyn I, Partanen T, Kromhout H, Svane O, Langård S, Järvholm B, Frentzel-Beyme R, Kauppinen T, Stücker I, et al. 2003b. Cancer mortality among European asphalt workers: an international epidemiological study. II. Exposure to bitumen fume and other agents. Am J Ind Med. 43:28–39.
  • Bolliet C, Juery C, Thiebaut B. 2013. Impact of oxidation process on polycyclic aromatic hydrocarbon (PAH) content in bitumen. J Occup Environ Hyg. 10:435–445.
  • Bolliet C, Kriech AJ, Juery C, Vaissiere M, Brinton MA, Osborn LV. 2015. Effect of temperature and process on quantity and composition of laboratory-generated bitumen emissions. J Occup Environ Hyg. 12:438–449.
  • Bosetti C, Boffetta P, La Vecchia C. 2007. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann Oncol. 18:431–446.
  • Brandt H, De Groot P. 1996. Emission and composition of fumes from current bitumen types. In: Paper presented at Eurasphalt and Eurobitume Congress. Strasbourg, France; May 7–10; p. 10.
  • Brandt H, De Groot P, Molyneux MKB, Tindle PE. 1985. Sampling and analysis of bitumen fumes. Ann Occup Hyg. 29:27–80.
  • Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–484.
  • Burstyn I, Boffetta P, Kauppinen T, Heikkilä P, Svane O, Partanen T, Stücker I, Frentzel-Beyme R, Ahrens W, Merzenich H, et al. 2003. Estimating exposures in the asphalt industry for an international epidemiological cohort study of cancer risk. Am J Ind Med. 43:3–17.
  • Burstyn I, Kromhout H. 2008. Still no evidence that coal tar exposure confounded the association between bitumen/asphalt fume and lung cancer in the cohort of European asphalt workers (Letter). J Occup Environ Hyg. 5:D73–D76.
  • Burstyn I, Kromhout H, Johansen C, Langard S, Kauppinen T, Shaham J, Ferro G, Boffetta P. 2007. Bladder cancer incidence and exposure to polycyclic aromatic hydrocarbons among asphalt pavers. Occup Environ Med. 64:520–526.
  • Burstyn I, Kromhout H, Kauppinen T, Heikkila P, Boffetta P. 2000. Statistical modelling of the determinants of historical exposure to bitumen and polycyclic aromatic hydrocarbons among paving workers. Ann Occup Hyg. 44:43–56.
  • Cavallari JM, Osborn LV, Snawder JE, Kriech AJ, Olsen LD, Herrick RF, McClean MD. 2012a. Predictors of dermal exposures to polycyclic aromatic compounds among hot-mix asphalt paving workers. Ann Occup Hyg. 56:125–137.
  • Cavallari JM, Osborn LV, Snawder JE, Kriech AJ, Olsen LD, Herrick RF, McClean MD. 2012b. Predictors of airborne exposures to polycyclic aromatic compounds and total organic matter among hot-mix asphalt paving workers and influence of work conditions and practices. Ann Occup Hyg. 56:138–147.
  • Cavallari JM, Zwack LM, Lange CR, Herrick RF, McClean MD. 2012c. Temperature-dependent emission concentrations of polycyclic aromatic hydrocarbons in paving and built-up roofing asphalts. Ann Occup Hyg. 56:148–160.
  • Clark CR, Burnett DM, Parker CM, Arp EW, Swanson MS, Minsavage GD, Kriech AJ, Osborn LV, Freeman JJ, Barter RA, et al. 2011. Asphalt fume dermal carcinogenicity potential: I. Dermal carcinogenicity evaluation of asphalt (bitumen) fume condensates. Regul Toxicol Pharmacol. 61:9–16.
  • dos Santos Silva I. 1999. Cancer epidemiology: principles and methods. Lyon, France: International Agency for Research on Cancer (IARC). [Online] http://www.iarc.fr/en/publications/pdfs-online/epi/cancerepi/CancerEpi.pdf.
  • Engholm G, Englund A. 1995. Morbidity and mortality patterns in Sweden. Occup Med. 10:261–268.
  • EPA. 1989. Risk Assessment Guidance for Superfund. Volume I: Human Health Evaluation Manual (Part A) (Interim Final). Office of Emergency and Remedial Response. EPA-540/1-89-002. December.
  • EPA. 1992. Dermal Exposure Assessment: Principles and Applications (Interim). Office of Health and Environmental Assessment, Exposure Assessment Group, Washington, DC, US EPA, Office of Research and Development, Center for Environmental Research Information, Cincinnati, OH. EPA-600/8-91-011B. January.
  • EPA. 1993. Provisional Guidance for Quantitative Risk Assessment of Polycyclic Aromatic Hydrocarbons (Final). EPA/600/R-93/089.
  • EPA. 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. Environmental Criteria and Assessment Office, Research Triangle Park, NC. EPA-600/8-90/066F. October. [accessed 2014 April 10] http://www.epa.gov/raf/publications/pdfs/RFCMETHODOLOGY.PDF.
  • EPA. 2000. Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures. Risk Assessment Forum Technical Panel; Office of Research and Development – NCEA, Office of Pesticide Programs, Office of Pollution Prevention and Toxics, Office of Water. EPA/630/R-00/002. August.
  • EPA. 2004. Risk Assessment Guidance for Superfund (RAGS). Volume I: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment) (Final). Office of Superfund Remediation and Technology Innovation. EPA/540/R/99/005. July.
  • EPA. 2005. Guidelines for Carcinogen Risk Assessment (Final). Risk Assessment Forum. EPA/630/P-03/001F. March.
  • EPA. 2010. Development of a Relative Potency Factor (RPF) Approach for Polycyclic Aromatic Hydrocarbon (PAH) Mixtures – In Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/635/R-08/012A. February.
  • EPA. 2011. Recommended Use of Body Weight(¾) as the Default Method in Derivation of the Oral Reference Dose (Final). Risk Assessment Forum. EPA/100/R11/0001. 50p.
  • EPA. 2012. Benchmark Dose Technical Guidance. Risk Assessment Forum. EPA/100/R-12/001. June.
  • EPA. 2014a. Toxicological Review of Benzo(a)Pyrene (CASRN 50-32-8) in Support of Summary Information on the Integrated Risk Information System (IRIS). National Center for Environmental Assessment (NCEA). EPA/635/R-14/312a. September.
  • EPA. 2014b. Toxicological Review of Benzo(a)Pyrene (CASRN 50-32-8) in Support of Summary Information on the Integrated Risk Information System (IRIS). National Center for Environmental Assessment (NCEA). EPA/635/R-14/312b. September.
  • EPA. 2017. Toxicological Review of Benzo(a)pyrene (CAS No. 50-32-8) (Final). National Center for Environmental Assessment (NCEA). EPA/635/R-17/003Fa. 234p., January. Accessed at https://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/0136tr.pdf.
  • Fayerweather WE. 2007. Meta-analysis of lung cancer in asphalt roofing and paving workers with external adjustment for confounding by coal tar. J Occup Environ Hyg. 4:175–200.
  • Fogleman EV, Eliot M, Michaud DS, Nelson HH, McClean MD, Langevin SM, Kelsey KT. 2015. Occupational asphalt is not associated with head and neck cancer. Occup Med. 65(7):570–573.
  • Fuhst R, Creutzenberg O, Ernst JH, Hansen T, Pohlmann G, Preiss A, Rittinghausen S. 2007. 24 Months inhalation carcinogenicity study of bitumen fumes in Wistar (WU) rats. J Occup Environ Hyg. 4:20–43.
  • Gamble JF, Nicolich MJ, Barone NJ, Vincent WJ. 1999. Exposure-response of asphalt fumes with changes in pulmonary function and symptoms. Scand J Work Environ Health. 25:186–206.
  • Godin B and Touitou E. 2007. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliver Rev. 59(11):1152–1161.
  • Goyak KO, McKee RH, Minsavage GD, McGowan C, Daughtrey WC, Freeman JJ. 2011. Paving asphalt products exhibit a lack of carcinogenic and mutagenic activity. Int J Toxicol. 30:492–497.
  • Hansen ES. 1989. Cancer incidence in an occupational cohort exposed to bitumen fumes. Scand J Work Environ Health. 15:101–105.
  • Hansen ES. 1991. Mortality of mastic asphalt workers. Scand J Work Environ Health. 17:20–24.
  • Hicks JB. 1995. Asphalt industry cross-sectional exposure assessment study. Appl Occup Environ Hyg. 10:840–848.
  • Hooiveld M, Burstyn I, Kromhout H, Heederik D. 2002. Quantitative risk assessment for lung cancer after exposure to bitumen fume. Toxicol Ind Health. 18:417–424.
  • [IOMC] Inter-Organization Programme for the Sound Management of Chemicals. 2004. Asphalt (Bitumen). World Health Organization (WHO) Concise International Chemical Assessment Document 59.
  • [IARC] International Agency for Research on Cancer. 2013. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 103: Bitumens and Bitumen Emissions. International Agency for Research on Cancer, World Health Organization (WHO). IARC Monograph No. 103.
  • Jongeneelen FJ, Scheepers PT, Groenendijk A, Van Aerts LA, Anzion RB, Bos RP, Veenstra SJ. 1988. Airborne concentrations, skin contamination, and urinary metabolite excretion of polycyclic aromatic hydrocarbons among paving workers exposed to coal tar derived road tars. Am Ind Hyg Assoc J. 49:600–607.
  • Knafla A, Petrovic S, Richardson M, Campbell J, Rowat C. 2011. Development and application of a skin cancer slope factor for exposures to benzo[a]pyrene in soil. Regul. Toxicol. Pharmacol. 59(1):101–110.
  • Kriech AJ, Kurek JT, Wissel HL, Osborn LV, Blackburn GR. 2002. Evaluation of worker exposure to asphalt paving fumes using traditional and nontraditional techniques. Aiha J. 63:628–635.
  • Kriech AJ, Osborn LV, Wissel HL, Kurek JT, Sweeney BJ, Peregrine CJG. 2004. Total versus inhalable sampler comparison study for the determination of asphalt fume exposures within the road paving industry. J Environ Monitor. 6:827–833.
  • Kriech AJ, Osborn LV, Wissel HL, Redman AP, Smith LA, Dobbs TE. 2007. Generation of bitumen fumes using two fume generation protocols and comparison to worker industrial hygiene exposures. J Occup Environ Hyg. 4:6–19.
  • Kriech AJ, Osborn LV, Prowell BD, Redman AP, West RC. 2011. Comparison of worker breathing zone exposures between hot mix asphalt and warm mix asphalt applications. Presented at the Second International Warm Mix Conference, St. Louis, MO, October 11–13. p. 18.
  • Kriech AJ, Schreiner CA, Osborn LV, Riley AJ. 2018. Assessing cancer hazards of bitumen emissions - A case study for complex petroleum substances. Crit Rev Toxicol. 48(2):121–142.
  • Machado ML, Beatty PW, Fetzer JC, Glickman AH, McGinnis EL. 1993. Evaluation of the relationship between PAH content and mutagenic activity of fumes from roofing and paving asphalts and coal tar pitch. Fundam Appl Toxicol. 21:492–499.
  • Maizlish N, Beaumont J, Singleton J. 1988. Mortality among California highway workers. Am J Ind Med. 13:363–379.
  • McClean MD, Osborn LV, Snawder JE, Olsen LD, Kriech AJ, Sjodin A, Li Z, Smith JP, Sammons DL, Herrick RF, Cavallari JM. 2012. Using urinary biomarkers of polycyclic aromatic compound exposure to guide exposure-reduction strategies among asphalt paving workers. Ann Occup Hyg. 56:1013–1024.
  • McClean MD, Rinehart RD, Ngo L, Eisen EA, Kelsey KT, Herrick RF. 2004. Inhalation and dermal exposure among asphalt paving workers. Ann Occup Hyg. 48:663–671.
  • Mickelsen RL, Shulman SA, Kriech AJ, Osborn LV, Redman AP. 2006. Status of worker exposure to asphalt paving fumes with the use of engineering controls. Environ Sci Technol. 40:5661–5667.
  • Milham SJ. 1997. Occupational Mortality in Washington State 1950–1989. Cincinnati (OH): National Institute for Occupational Safety and Health.
  • Moody RP, Joncas J, Richardson M, Chu I. 2007. Contaminated soils (I): in vitro dermal absorption of benzo[a]pyrene in human skin. J Toxicol Environ Health Part A. 70:1858–1865.
  • Mundt KA, Dell LD, Crawford L, Sax SN, Boffetta P. 2018. Cancer risk associated with exposure to bitumen and bitumen fumes: an updated systematic review and meta-analysis. J Occup Environ Med. 60:e6–e54.
  • [NAPA and EAPA] National Asphalt Pavement Association (NAPA), European Asphalt Pavement Association (EAPA). 2011. The Asphalt Paving Industry – A Global Perspective: Production, Use, Properties, and Occupational Exposure Reduction Technologies and Trends (Third Edition). Global Series 101. p. 37.
  • [NIOSH] National Institute for Occupational Safety and Health. 2000. Hazard Review: Health Effects of Occupational Exposures to Asphalt. DHHS (NIOSH) Publication No. 2001–110. December.
  • [NIOSH] National Institute for Occupational Safety and Health. 2001. Health Hazard Evaluation Report: Crumb-Rubber Modified Asphalt Paving: Occupational Exposures and Acute Health Effects. HETA 2001-0536-2864. 51 p.
  • Olsen LD, Snawder JE, Kriech AJ, Osborn LV. 2011. Development of a 5-layer passive organic dermal (POD) sampler. Polycycl Aromat Compd. 31:154–172.
  • Olsson A, Kromhout H, Agostini M, Hansen J, Lassen CF, Johansen C, Kjaerheim K, Langård S, Stücker I, Ahrens W, et al. 2010. A case-control study of lung cancer nested in a cohort of European asphalt workers. Environ Health Perspect. 118:1418–1424.
  • Osborn LV, Kurek JT, Kriech AJ, Fehsenfeld FM. 2001. Luminescence spectroscopy as a screening tool for the potential carcinogenicity of asphalt fumes. J Environ Monit. 3:185–190.
  • Osborn LV, Snawder JE, Kriech AJ, Cavallari JM, McClean MD, Herrick RF, Blackburn GR, Olsen LD. 2013. Personal breathing zone exposures among hot-mix asphalt paving workers; preliminary analysis for trends and analysis of work practices that resulted in the highest exposure concentrations. J Occup Environ Hyg. 10:663–673.
  • Osborn LV, Snawder JE, Olsen LD, Kriech AJ, Cavallari JM, Herrick RF, McClean MD, Blackburn GR. 2011. Pilot study for the investigation of personal breathing zone and dermal exposure using levels of polycyclic aromatic compounds (PAC) and PAC metabolites in the urine of hot-mix asphalt paving workers. Polycycl Aromat Compd. 31:173–200.
  • Partanen T, Boffetta P. 1994. Cancer risk in asphalt workers and roofers: review and meta-analysis of epidemiologic studies. Am J Ind Med. 26:721–740.
  • Peto R. 1977. Epidemiology, multistage models, and short-term mutagenicity tests. In: Hiatt HH, Watson JD, Winstein JA, editors. The origins of human cancer. New York: Cold Spring Harbor Laboratory. p. 1403–1428.
  • Peto R. 2015. Quantitative implications of the approximate irrelevance of mammalian body size and lifespan to lifelong cancer risk. Phil. Trans. R. Soc. B. 370:20150198.
  • Purdue MP, Jarvholm B, Bergdahl IA, Hayes RB, Baris D. 2006. Occupational exposures and head and neck cancers among Swedish construction workers. Scand J Work Environ Health. 32:270–275.
  • Randem BG, Burstyn I, Langård S, Svane O, Järvholm B, Kauppinen T, Bergdahl IA, Johansen C, Hansen J, Partanen T, et al. 2004. Cancer incidence of Nordic asphalt workers. Scand J Work Environ Health. 30:350–355.
  • Rhomberg LR, Mayfield DB, Goodman JE, Butler EL, Nascarella MA, Williams DR. 2015. Quantitative cancer risk assessment for occupational exposures to asphalt fumes during built-up roofing asphalt (BURA) operations. Crit Rev Toxicol. 45(10):873–918.
  • Roy TA, Kriech AJ, Mackerer CR. 2007. Percutaneous absorption of polycyclic aromatic compounds from bitumen fume condensate. J Occup Environ Hyg. 4:137–143.
  • Roy TA, Kriech AJ, Osborn LV. 2018. Percutaneous absorption of polycyclic aromatic compounds from fume condensates of paving and built up roofing asphalts. (Submitted). https://www.tandfonline.com/doi/full/10.1080/10406638.2018.1509362.
  • Simmers MH. [California College of Medicine, Dept. of Pathology; Academia]. 1964. Petroleum asphalt inhalation by mice. Effects of aerosols and smoke on the tracheobronchial tree and lungs. Arch Environ Health. 9:727–734.
  • Sivak A, Niemeier R, Lynch D, Beltis K, Simon S, Salomon R, Latta R, Belinky B, Menzies K, Lunsford A, et al. 1997. Skin carcinogenicity of condensed asphalt roofing fumes and their fractions following dermal application to mice. Cancer Lett. 117:113–123.
  • Speight JG. 1999. The chemistry and technology of petroleum. 3rd ed. New York: Marcel Dekker.
  • Storm JE, Collier SW, Stewart RF, Bronaugh RL. 1990. Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity. Fundam Appl Toxicol. 15:132–141.
  • Tollis M, Boddy AM, Maley CC. 2017. Peto’s paradox: how has evolution solved the problem of cancer prevention? BMC Biol. 15(1):60.
  • Tompa A, Jakab MG, Biro A, Magyar B, Major J. 2007. Health, genotoxicology, and immune status of road pavers in Hungary. J Occup Environ Hyg. 4:154–162.
  • Trumbore DC, Osborn L, Blackburn G, Niebo R, Kriech A, Maxim LD. 2011. Effect of oxidation and extent of oxidation on biologically active PACs in asphalt products. Inhal Toxicol. 23:745–761.
  • Vaananen V, Hameila M, Kalliokoski P, Nykyri E, Heikkila P. 2005. Dermal exposure to polycyclic aromatic hydrocarbons among road pavers. Ann Occup Hyg. 49:167–178.
  • Watts RR, Wallingford KM, Williams RW, House DE, Lewtas J. 1998. Airborne exposures to PAH and PM2.5 particles for road paving workers applying conventional asphalt and crumb rubber modified asphalt. J Expo Anal Environ Epidemiol. 8:213–229.
  • Wong O. 1983. An epidemiologic mortality study of a cohort of chemical workers potentially exposed to formaldehyde, with a discussion on SMR and PMR. In: Gibson, JE, ed. Formaldehyde toxicity. Washington, DC: Hemisphere Publishing Corp; p. 256–272.
  • Wong O, Bailey WJ, Amsel J. 1992. Cancer mortality and incidence in mastic asphalt workers (Letter). Scand J Work Environ Health. 18:133–135.
  • Zahm SH, Brownson RC, Chang JC, Davis JR. 1989. Study of lung cancer histologic types, occupation, and smoking in Missouri. Am J Ind Med. 15:565–579.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.